PATIENTS    |   BECOME A PROVIDER    |   PROVIDER PORTAL    |   PROVIDER SEARCH    |   REIMBURSEMENT

How Shockwave Therapy Compares to Cortisone Injections

Home > Article > Blog > How Shockwave Therapy Compares to Cortisone Injections
How Shockwave Therapy Compares to Cortisone Injections

Musculoskeletal disorders are among the most common clinical challenges, necessitating interventions that address both symptoms and underlying pathology while minimizing adverse effects. Two prominent treatment modalities are extracorporeal shockwave therapy (ESWT) and corticosteroid injections. 

Shockwave therapy is a non-invasive technique that employs acoustic waves to stimulate cellular responses, promoting tissue regeneration without pharmacological agents. Conversely, corticosteroid injections deliver synthetic glucocorticoids directly into affected tissues, exerting potent anti-inflammatory effects by modulating gene transcription and suppressing pro-inflammatory cytokines. 

The choice between these therapies depends on various factors, including the specific condition, patient comorbidities, and desired outcomes. Understanding the distinct mechanisms and applications of ESWT and corticosteroid injections enables clinicians to tailor treatment strategies effectively for optimal patient care.

What Is Shockwave Therapy and How Does It Work?

Extracorporeal Shockwave Therapy (ESWT) is a non-invasive treatment that delivers acoustic waves to targeted musculoskeletal tissues, inducing mechanical stress that activates cellular responses. This mechanotransduction process stimulates the release of growth factors such as VEGF, TGF-β1, PCNA, and BMP-2, promoting neovascularization, angiogenesis, and tissue regeneration. 

Shockwave therapy also activates fibroblasts, osteoblasts, chondrocytes, and mesenchymal stem cells, facilitating tissue remodeling and repair. Shockwave therapy initiates endogenous healing mechanisms by inducing controlled microtrauma, offering a regenerative approach to treating various musculoskeletal conditions with a lasting effect.

Benefits and Medical Indications of Shockwave Therapy

The clinical applications of shockwave therapy span multiple specialties due to its capacity to address both chronic and acute musculoskeletal conditions without surgical intervention. Modern protocols typically involve treatments administered at 1-2 week intervals, often requiring 3-5 sessions to achieve optimal therapeutic outcomes.

Medical indications for shockwave therapy include:

  • Tendinopathies including plantar fasciitis, Achilles tendinopathy, patellar tendinopathy, and lateral epicondylitis.
  • Calcific shoulder tendinitis with demonstrated calcium deposit reduction.
  • Myofascial pain syndromes and trigger points.
  • Non-union fractures and stress fractures.
  • Greater trochanteric pain syndrome.
  • Osteonecrosis in early stages.
  • Wound healing acceleration.

Among advanced shockwave technologies, SoftWave Therapy utilizes a distinctive approach through its patented parabolic reflector system. It generates broad-focused acoustic waves that distribute energy across a broader treatment area without inducing significant microtrauma. Its configuration allows simultaneous treatment of superficial and deep tissues while stimulating cellular communication networks that modulate inflammatory responses and enhance tissue regeneration pathways.

What Are Cortisone Injections and How Do They Work?

Corticosteroid injections are a standard intervention for inflammatory musculoskeletal conditions, delivering synthetic glucocorticoids like methylprednisolone or triamcinolone directly into affected joints, tendon sheaths, or bursae. These agents bind to intracellular glucocorticoid receptors, translocate to the nucleus, and modulate gene transcription, suppressing pro-inflammatory cytokines such as IL-1, IL-6, and TNF-α while enhancing anti-inflammatory proteins. 

This mechanism reduces inflammation, alleviates pain, and improves function in the targeted tissues. Often combined with local anesthetics for immediate relief, corticosteroid injections provide short-term benefits but may not address underlying degenerative processes.

Benefits and Medical Indications of Cortisone Injections

Corticosteroid injections provide rapid symptomatic relief for inflammatory conditions, often producing noticeable improvement within 24-72 hours post-administration. The localized delivery method allows for concentrated anti-inflammatory action at pathological sites while minimizing systemic exposure and associated adverse effects. Modern formulations with varying particle sizes and solubility profiles enable clinicians to select preparations appropriate for specific anatomical locations and clinical presentations.

Medical indications for cortisone injections include:

  • Inflammatory arthropathies, including rheumatoid arthritis and psoriatic arthritis.
  • Osteoarthritis with inflammatory components, particularly in weight-bearing joints.
  • Adhesive capsulitis (frozen shoulder).
  • Carpal tunnel syndrome and other nerve entrapment conditions.
  • De Quervain’s tenosynovitis and trigger finger.
  • Bursitis affecting the subacromial, trochanteric, and prepatellar regions.
  • Acute gout and pseudogout flares.

READ: Alternatives to Cortisone Shots

Key Differences Between Shockwave Therapy And Cortisone Injections

The fundamental distinction between these modalities lies in their therapeutic approach and physiological impact on tissues. Exploring these differences is key to choosing the strategy best suits your needs and your patients’ expected outcomes.

Treatment Mechanism

Shockwave therapy operates through mechanotransduction, converting acoustic energy into biological responses, promoting tissue healing and stimulating cellular activity, which activates natural repair processes within damaged tissues. Cortisone injections function through pharmacological pathways, delivering synthetic glucocorticoids that bind to cellular receptors and inhibit inflammatory mediator production within the target tissues.

Side Effects Profile

Shockwave therapy demonstrates minimal adverse effects beyond transient discomfort during application and occasional post-treatment soreness, with no documented long-term tissue deterioration. Cortisone injections carry recognized risks, including tendon weakening, cartilage degradation, subcutaneous atrophy, post-injection flares, and potential increased infection susceptibility with repeated administration.

Cost Considerations

Shockwave therapy requires initial capital investment in equipment but offers sustainable revenue without recurring supply costs beyond maintenance. Cortisone injections involve ongoing expenditure for pharmaceutical products, needles, and sterilization protocols, making per-treatment costs relatively stable. The operational economics favor shockwave therapy for high-volume practices when calculated over extended timeframes.

Treatment Protocol

Shockwave therapy typically requires multiple sessions (3-5) administered weekly, each lasting approximately 10-15 minutes. Cortisone injections are generally administered as single interventions with potential repeat administrations limited to 3-4 times annually to prevent tissue degradation. 

Tissue Penetration

Modern shockwave devices achieve effective penetration depths of 0-12cm, depending on energy settings and applicator configuration, allowing treatment of superficial and deep structures. Cortisone injections deliver medication precisely to target structures but depend on accurate needle placement and limited diffusion from injection sites, restricting therapeutic reach to the immediate anatomical region.

Duration of Effect

Shockwave therapy outcomes demonstrate progressive improvement over weeks following treatment, with numerous applications maintaining benefits beyond 12 months. Cortisone injections provide more rapid relief but demonstrate temporal decay of effect, with benefits typically diminishing within 3-6 months and potentially reduced efficacy with repeated administrations over time.

Comparative Table: Shockwave Therapy vs. Cortisone Injections

ParameterShockwave TherapyCortisone Injections
MechanismMechanical stimulation induces biological healingPharmacological anti-inflammatory action
Treatment Sessions3-5 sessions at weekly intervalsSingle administration with limits on frequency
Duration10-15 minutes per session5-10 minutes including preparation
Adverse EffectsMinimal transient discomfortPotential tissue atrophy and degeneration
Tissue Penetration0-12cm depending on deviceLimited to the injection site and surrounding tissues
Effect LongevityProgressive improvement for 6- 12+ monthsDiminishing effect over 3-6 months
ContraindicationsPregnancy, malignancy in the treatment areaInfection, coagulopathy, and certain comorbidities
Equipment CostHigher initial investmentLower equipment requirements

Which Option Is More Suitable for Your Patients?

The clinical decision between shockwave therapy and cortisone injections should incorporate multiple patient-specific factors, including chronicity, previous treatment responses, contraindications, and therapeutic goals. For acute inflammatory conditions requiring immediate symptomatic management, cortisone injections may represent an appropriate first-line intervention. However, for chronic tendinopathies and conditions characterized by failed healing responses, shockwave therapy offers advantages through tissue regeneration rather than symptom suppression.

Patient selection criteria should consider comorbidities that contraindicate either modality. Advanced technologies such as the SoftWave Gold Li Series offer expanded applications through adjustable energy settings and specialized applicators, enabling treatment customization based on anatomical location and tissue characteristics. 

For clinics evaluating the best shockwave therapy machines for providers, SoftWave offers a scalable, research-backed option that expands treatment capabilities without increasing clinical complexity. Explore the newest research on SoftWave to learn more about its efficacy and positive outcomes for patients. 

SoftWave Therapy: Your Next Step Toward Patient Care

The comparative analysis between shockwave therapy and cortisone injections reveals distinct advantages for each modality within specific clinical contexts. While cortisone injections continue to serve an important role in managing acute inflammatory conditions, shockwave therapy offers superior long-term outcomes by promoting tissue healing and regeneration rather than purely symptomatic management.

SoftWave Therapy represents a significant advancement in shockwave technology through its patented parabolic reflector design that generates uniform wave distribution across treatment areas. This system produces parallel acoustic shockwaves that address superficial and deep tissues, promoting angiogenesis, modulating inflammation, and stimulating growth factor production without causing microtrauma. With FDA-cleared applications spanning orthopedics, sports medicine, physical therapy, urology, and podiatry, this technology expands treatment capabilities while maintaining procedural simplicity and patient comfort. 

Become a SoftWave Provider Today and improve patient care.

Related Posts